$HQY
HEALTHEQUITY, INC.

2020 Q3 Form 10-Q Financial Statement

#000142833620000025 Filed on September 09, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3 2019 Q2
Revenue $176.0M $86.62M $87.05M
YoY Change 103.22% 21.89% 24.53%
Cost Of Revenue $74.26M $28.18M $29.30M
YoY Change 163.47% 15.07% 14.68%
Gross Profit $101.8M $58.44M $57.75M
YoY Change 74.17% 25.48% 30.2%
Gross Profit Margin 57.82% 67.46% 66.34%
Selling, General & Admin $32.66M $17.65M $17.68M
YoY Change 85.01% 16.63% 23.05%
% of Gross Profit 32.09% 30.21% 30.61%
Research & Development $30.65M $11.65M $10.91M
YoY Change 163.24% 38.66% 36.67%
% of Gross Profit 30.12% 19.93% 18.88%
Depreciation & Amortization $4.100M $1.000M $4.773M
YoY Change 310.0% 25.0% 5.6%
% of Gross Profit 4.03% 1.71% 8.26%
Operating Expenses $92.76M $33.58M $30.08M
YoY Change 176.26% 34.24% 26.28%
Operating Profit $9.028M $24.86M $27.68M
YoY Change -63.69% 15.31% 34.75%
Interest Expense $8.895M $67.00K $63.00K
YoY Change 13176.12% -68.5%
% of Operating Profit 98.53% 0.27% 0.23%
Other Income/Expense, Net -$9.719M -$1.128M $23.60M
YoY Change 761.61% 1404.0% -2360100.0%
Pretax Income -$691.0K $23.74M $51.28M
YoY Change -102.91% 10.46% 149.66%
Income Tax -$543.0K $4.370M $9.456M
% Of Pretax Income 18.41% 18.44%
Net Earnings -$148.0K $19.37M $41.82M
YoY Change -100.76% -13.99% 85.24%
Net Earnings / Revenue -0.08% 22.36% 48.04%
Basic Earnings Per Share $0.00 $0.30 $0.67
Diluted Earnings Per Share $0.00 $0.30 $0.65
COMMON SHARES
Basic Shares Outstanding 72.34M shares 64.22M shares 62.33M shares
Diluted Shares Outstanding 72.34M shares 65.58M shares 63.90M shares

Balance Sheet

Concept 2020 Q3 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $268.9M $815.2M $329.3M
YoY Change -67.01% 169.13% 22.05%
Cash & Equivalents $268.9M $815.2M $329.3M
Short-Term Investments
Other Short-Term Assets $43.98M $11.00M $8.244M
YoY Change 299.87% -6.21% -23.17%
Inventory
Prepaid Expenses
Receivables $70.24M $27.36M $27.02M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $383.1M $853.5M $364.6M
YoY Change -55.11% 151.25% 20.02%
LONG-TERM ASSETS
Property, Plant & Equipment $34.53M $9.873M $8.481M
YoY Change 249.72% 11.32% -1.68%
Goodwill $1.334B $4.651M $4.651M
YoY Change 28577.88% 0.0% 0.0%
Intangibles $783.1M $88.77M $81.44M
YoY Change 782.19% 7.89% -0.87%
Long-Term Investments $209.0K $209.0K
YoY Change 109.0% 109.0%
Other Assets $34.66M $22.31M $21.51M
YoY Change 55.34% 23.58% 18.02%
Total Long-Term Assets $2.281B $244.8M $232.1M
YoY Change 831.79% 113.1% 103.09%
TOTAL ASSETS
Total Short-Term Assets $383.1M $853.5M $364.6M
Total Long-Term Assets $2.281B $244.8M $232.1M
Total Assets $2.664B $1.098B $596.6M
YoY Change 142.58% 141.6% 42.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.71M $2.740M $1.964M
YoY Change 327.3% 54.89% -36.89%
Accrued Expenses $37.42M $19.39M $9.127M
YoY Change 92.99% 247.71% 42.56%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $54.69M
YoY Change
Total Short-Term Liabilities $153.8M $37.14M $23.38M
YoY Change 314.03% 117.59% 36.28%
LONG-TERM LIABILITIES
Long-Term Debt $952.9M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $8.210M $735.0K $387.0K
YoY Change 1017.01% -72.71% -84.52%
Total Long-Term Liabilities $1.170B $735.0K $387.0K
YoY Change 159120.27% -85.04% -90.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $153.8M $37.14M $23.38M
Total Long-Term Liabilities $1.170B $735.0K $387.0K
Total Liabilities $1.324B $81.31M $67.34M
YoY Change 1528.41% 269.87% 219.8%
SHAREHOLDERS EQUITY
Retained Earnings $213.2M $233.0M $213.7M
YoY Change -8.52% 62.91% 77.28%
Common Stock $8.000K $7.000K $6.000K
YoY Change 14.29% 16.67% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.340B $1.017B $529.3M
YoY Change
Total Liabilities & Shareholders Equity $2.664B $1.098B $596.6M
YoY Change 142.58% 141.6% 42.73%

Cashflow Statement

Concept 2020 Q3 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income -$148.0K $19.37M $41.82M
YoY Change -100.76% -13.99% 85.24%
Depreciation, Depletion And Amortization $4.100M $1.000M $4.773M
YoY Change 310.0% 25.0% 5.6%
Cash From Operating Activities $53.70M $31.50M $25.34M
YoY Change 70.48% 5.35% 11.59%
INVESTING ACTIVITIES
Capital Expenditures -$30.40M -$6.800M $1.126M
YoY Change 347.06% 30.77% 0.45%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$53.80M
YoY Change -100.0% 26800.0%
Cash From Investing Activities -$30.40M -$6.900M -$61.73M
YoY Change 340.58% 27.78% 1716.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change
Cash From Financing Activities 74.60M 461.2M $4.229M
YoY Change -83.82% 5456.63% -58.4%
NET CHANGE
Cash From Operating Activities 53.70M 31.50M $25.34M
Cash From Investing Activities -30.40M -6.900M -$61.73M
Cash From Financing Activities 74.60M 461.2M $4.229M
Net Change In Cash 97.90M 485.8M -$32.17M
YoY Change -79.85% 1381.1% -209.13%
FREE CASH FLOW
Cash From Operating Activities $53.70M $31.50M $25.34M
Capital Expenditures -$30.40M -$6.800M $1.126M
Free Cash Flow $84.10M $38.30M $24.21M
YoY Change 119.58% 9.12% 12.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001428336
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-07-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36568
dei Entity Registrant Name
EntityRegistrantName
HEALTHEQUITY, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2383166
dei Entity Address Address Line1
EntityAddressAddressLine1
15 West Scenic Pointe Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Draper,
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84020
dei City Area Code
CityAreaCode
801
dei Local Phone Number
LocalPhoneNumber
727-1000
dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
HQY
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
76863514 shares
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
268910000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
191726000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1954000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1216000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
70235000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
70863000 USD
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
43982000 USD
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
34711000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
383127000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
297300000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34528000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33486000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
95095000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
83178000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
783106000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
783279000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
1333808000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
1332631000 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
59000 USD
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
18000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
34658000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35089000 USD
CY2020Q3 us-gaap Assets
Assets
2664381000 USD
CY2020Q1 us-gaap Assets
Assets
2564981000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
11708000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3980000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
36435000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
50121000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
37424000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
46372000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
54688000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
39063000 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13521000 USD
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12401000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
153776000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
151937000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
952898000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1181615000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
79304000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
68017000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8210000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2625000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
129857000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
130492000 USD
CY2020Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1170269000 USD
CY2020Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1382749000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
1324045000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
1534686000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76872000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76872000 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71051000 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71051000 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
7000 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1127136000 USD
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
818774000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
213192000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
211514000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1340336000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1030295000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2664381000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2564981000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
176039000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
86623000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
366050000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
173675000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
74255000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28183000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
156192000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
57482000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
101784000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
58440000 USD
us-gaap Gross Profit
GrossProfit
209858000 USD
us-gaap Gross Profit
GrossProfit
116193000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12167000 USD
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8391000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
23622000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17361000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30654000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11645000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
61732000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22550000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20493000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9262000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39491000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17971000 USD
CY2020Q3 hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
19077000 USD
CY2019Q3 hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
1494000 USD
hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
37779000 USD
hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
2985000 USD
CY2020Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
10365000 USD
CY2019Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
2784000 USD
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
23135000 USD
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
2784000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
92756000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
33576000 USD
us-gaap Operating Expenses
OperatingExpenses
185759000 USD
us-gaap Operating Expenses
OperatingExpenses
63651000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
9028000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
24864000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
24099000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
52542000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
8895000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
67000 USD
us-gaap Interest Expense
InterestExpense
21158000 USD
us-gaap Interest Expense
InterestExpense
130000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-824000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4370000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-325000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13826000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1061000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1588000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
22602000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9719000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1128000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22746000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22472000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-691000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23736000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1353000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
75014000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-543000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-148000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-148000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
19366000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
19366000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1678000 USD
us-gaap Net Income Loss
NetIncomeLoss
1678000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
61188000 USD
us-gaap Net Income Loss
NetIncomeLoss
61188000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.94
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72343000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64220000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71669000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63289000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72343000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65583000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72971000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64785000 shares
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1040650000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
529299000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1030295000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
477079000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1340336000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
1017031000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1340336000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
1017031000 USD
us-gaap Net Income Loss
NetIncomeLoss
1678000 USD
us-gaap Net Income Loss
NetIncomeLoss
61188000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
56106000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9722000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
18834000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
13618000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2533000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
31000 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
27285000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1925000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-568000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
7868000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
152000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1689000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3187000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4962000 USD
hqy Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-5563000 USD
hqy Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-1286000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6047000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1083000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-13854000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-5926000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6017000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4942000 USD
hqy Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
-5723000 USD
hqy Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
-1210000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
5477000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
331000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
68662000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
56831000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8987000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3492000 USD
us-gaap Payments For Software
PaymentsForSoftware
21787000 USD
us-gaap Payments For Software
PaymentsForSoftware
9518000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
24922000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1736000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
53845000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-55696000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-68591000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
287318000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
458881000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
215625000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
hqy Payments To Settle Client Held Funds
PaymentsToSettleClientHeldFunds
10292000 USD
hqy Payments To Settle Client Held Funds
PaymentsToSettleClientHeldFunds
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2817000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6564000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
64218000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
465445000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
77184000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
453685000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
191726000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
361475000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
268910000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
815160000 USD
us-gaap Interest Paid Net
InterestPaidNet
17659000 USD
us-gaap Interest Paid Net
InterestPaidNet
101000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
798000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9119000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1104000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3000 USD
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
1177000 USD
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
0 USD
hqy Exerciseof Stock Options Receivable
ExerciseofStockOptionsReceivable
66000 USD
hqy Exerciseof Stock Options Receivable
ExerciseofStockOptionsReceivable
87000 USD
hqy Stock Issuance Costs Incurred But Not Yet Paid
StockIssuanceCostsIncurredButNotYetPaid
540000 USD
hqy Stock Issuance Costs Incurred But Not Yet Paid
StockIssuanceCostsIncurredButNotYetPaid
386000 USD
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 USD
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
345000 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Certain reclassifications have been made to prior year amounts to conform to the current year presentation.
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-148000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
19366000 USD
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64220000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71669000 shares
us-gaap Net Income Loss
NetIncomeLoss
1678000 USD
us-gaap Net Income Loss
NetIncomeLoss
61188000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72343000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64220000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71669000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63289000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72343000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63289000 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1363000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1302000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1496000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72343000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65583000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72971000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64785000 shares
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.94
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2100000 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000 shares
us-gaap Depreciation
Depreciation
8000000.0 USD
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57927000 USD
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
49243000 USD
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23399000 USD
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15757000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34528000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33486000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
4100000 USD
CY2019Q3 us-gaap Depreciation
Depreciation
1000000.0 USD
CY2020Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
600000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1400000 USD
us-gaap Depreciation
Depreciation
1800000 USD
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
11500000 USD
CY2020Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3700000 USD
hqy Contract With Customer Recognition Term Interchange Arrangement
ContractWithCustomerRecognitionTermInterchangeArrangement
P10Y
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
3925000 USD
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
1086000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
8249000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
2160000 USD
CY2020Q3 us-gaap Sublease Income
SubleaseIncome
450000 USD
CY2019Q3 us-gaap Sublease Income
SubleaseIncome
0 USD
us-gaap Sublease Income
SubleaseIncome
900000 USD
us-gaap Sublease Income
SubleaseIncome
0 USD
CY2020Q3 us-gaap Lease Cost
LeaseCost
3475000 USD
CY2019Q3 us-gaap Lease Cost
LeaseCost
1086000 USD
us-gaap Lease Cost
LeaseCost
7349000 USD
us-gaap Lease Cost
LeaseCost
2160000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
6468000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1829000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
17480000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
199000 USD
CY2020Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
76000 USD
CY2019Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1884000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
676000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
3227000 USD
CY2020Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
0 USD
CY2019Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
3774000 USD
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
0 USD
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
27285000 USD
CY2020Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
-28000 USD
CY2019Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6596000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
66000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
7780000 USD
CY2020Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
928000 USD
CY2019Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
123000 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
2198000 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
130000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-824000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1061000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1588000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
22602000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-500000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
929264000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
879597000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
146946000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
98851000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
782318000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
780746000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
783106000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
783279000 USD
CY2020Q3 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
10300000 USD
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
20600000 USD
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
7700000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24500000 USD
CY2019Q3 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
3800000 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4000000.0 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
48100000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7900000 USD
CY2020Q3 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
1200000 USD
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2019Q3 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2020Q3 hqy Goodwill Period Increase Decrease Excluding Purchase Accounting Adjustments
GoodwillPeriodIncreaseDecreaseExcludingPurchaseAccountingAdjustments
0 USD
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2018Q2 hqy Loss Contingency Number Of Lawsuits
LossContingencyNumberOfLawsuits
2 lawsuit
CY2018Q3 hqy Loss Contingency Number Of Lawsuits
LossContingencyNumberOfLawsuits
2 lawsuit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-300000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.786
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.240
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.184
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.184
CY2020Q3 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.629
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.574
CY2019Q3 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.048
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.046
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
9800000 USD
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
9400000 USD
CY2020Q3 hqy Unrecognized Tax Benefit Net
UnrecognizedTaxBenefitNet
600000 USD
CY2020Q1 hqy Unrecognized Tax Benefit Net
UnrecognizedTaxBenefitNet
500000 USD
CY2020Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
9000000.0 USD
CY2020Q3 hqy Debt Instrument Covenant Description Interest Coverage Ratio
DebtInstrumentCovenantDescriptionInterestCoverageRatio
3.00 Rate
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1026600000 USD
CY2020Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
19000000.0 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
1007600000 USD
CY2020Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
19000000.0 USD
CY2020Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0216
CY2020Q3 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0270
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
23400000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
62500000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
70300000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
101600000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
768800000 USD
CY2020Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1026600000 USD
hqy Debt Instrument Covenant Description Acquisition Threshold For Maximum Total Net Leverage Ratio
DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio
100000000.0 USD
hqy Share Based Compensation Shares Authorized Under Stock Option Plans Granted
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted
66.06
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11438000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7590000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18834000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13618000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2040000 shares
CY2020Q1 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding
0.10
CY2020Q1 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding
82.39
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
30.35
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M24D
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
74009000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
16000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
66.06
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
116000 shares
hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Exercised
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised
0.10
hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Exercised
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised
44.53
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
23.65
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
7000 shares
hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Forfeited
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited
25.45
hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Forfeited
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited
44.53
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
34.31
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1933000 shares
CY2020Q3 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding
0.10
CY2020Q3 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding
82.39
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
31.04
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y4M24D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
43958000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1933000 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
31.04
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y4M24D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
43958000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1596000 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
26.12
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
41916000 USD

Files In Submission

Name View Source Status
0001428336-20-000025-index-headers.html Edgar Link pending
0001428336-20-000025-index.html Edgar Link pending
0001428336-20-000025.txt Edgar Link pending
0001428336-20-000025-xbrl.zip Edgar Link pending
exhibit101-transitiona.htm Edgar Link pending
exhibit311-ceo302xfy21.htm Edgar Link pending
exhibit312-cfo302xfy21.htm Edgar Link pending
exhibit321-ceo906xfy21.htm Edgar Link pending
exhibit322-cfo906xfy21.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hqy-20200731.htm Edgar Link pending
hqy-20200731.xsd Edgar Link pending
hqy-20200731_cal.xml Edgar Link unprocessable
hqy-20200731_def.xml Edgar Link unprocessable
hqy-20200731_htm.xml Edgar Link completed
hqy-20200731_lab.xml Edgar Link unprocessable
hqy-20200731_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending